Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD44 | P16070 | 2/20 | 0.55 |
| ▸ | PNMT | P11086 | 2/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 4/20 | 0.36 |
| ▸ | RYR2 | Q92736 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
| ▸ | PRCP | P42785 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7423515 | 0.82 | CD44 (0.47) | CD44PNMTMAOBHTR2CKDM4E | |
| Hydrochloric Acid SCHEMBL7423542 | 0.81 | CD44 (0.46) | CD44PNMTMAOBKDM4EMEN1 | |
| SCHEMBL1119383 | 0.78 | CD44 (0.46) | CD44PNMTMAOBHTR2CKDM4E | |
| SCHEMBL30425286 | 0.78 | CD44 (0.46) | CD44PNMTMAOBHTR2CKDM4E | |
| SCHEMBL27380732 | 0.77 | CD44 (0.41) | CD44PNMTMAOBHTR2CRYR2 | |
| SCHEMBL6615323 | 0.77 | CD44 (0.41) | CD44PNMTMAOBHTR2CRYR2 | |
| SCHEMBL1082367 | 0.74 | SRC (0.49) | CD44HTR2CKDM4EMEN1ALDH1A1 | |
| SCHEMBL29661329 | 0.74 | SRC (0.49) | CD44HTR2CKDM4EMEN1ALDH1A1 | |
| SCHEMBL9013032 | 0.71 | PARP1 (0.36) | CD44KDM4EMEN1ALDH1A1GAA | |
| SCHEMBL29771844 | 0.71 | CD44 (1.00) | CD44PNMTMAOBHTR2CPARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0538297-B9 | ANTIVIRAL TETRAHYDROIMIDAZO 1,4]BENZODIAZEPIN-2-(THIO)ONES | JANSSEN PHARMACEUTICA NV (BE) | 2002-10-16 | — | — | EP | claimed |
| EP-0538297-B1 | ANTIVIRAL TETRAHYDROIMIDAZO 1,4]BENZODIAZEPIN-2-(THIO)ONES | JANSSEN PHARMACEUTICA NV (BE) | 2001-09-19 | — | — | EP | claimed |
| EP-0417840-B1 | Antiviral tetrahydroimidazo [1,4]-benzodiazepines | JANSSEN PHARMACEUTICA NV (BE) | 1994-12-07 | — | — | EP | claimed |
| EP-0538297-A1 | ANTIVIRAL TETRAHYDROIMIDAZO 1,4]BENZODIAZEPIN-2-(THIO)ONES | JANSSEN PHARMACEUTICA N.V. (BE) | 1993-04-28 | — | — | EP | claimed |
| EP-0384522-B1 | Antiviral tetrahydroimidazo[1,4]benzodiazepin-2-thiones | JANSSEN PHARMACEUTICA N.V. (BE) | 1993-01-13 | — | — | EP | claimed |
| EP-0336466-B1 | ANTIVIRAL TETRAHYDROIMIDAZO (1,4) BENZODIAZEPIN-2-ONES | JANSSEN PHARMACEUTICA N.V. (BE) | 1992-12-30 | — | — | EP | claimed |
| EP-0491751-A1 | ANTIVIRAL TETRAHYDROIMIDAZO 1,4]BENZODIAZEPINES | JANSSEN PHARMACEUTICA N.V. (BE) | 1992-07-01 | — | — | EP | claimed |
| WO-1992000979-A1 | ANTIVIRAL TETRAHYDROIMIDAZO[1,4]BENZODIAZEPIN-2-(THIO)ONES | JANSSEN PHARMACEUTICA N.V. (BE) | 1992-01-23 | — | — | WO | claimed |
| WO-1991004255-A1 | ANTIVIRAL TETRAHYDROIMIDAZO[1,4]BENZODIAZEPINES | JANSSEN PHARMACEUTICA N.V. (BE) | 1991-04-04 | — | — | WO | claimed |
| EP-0417840-A1 | Antiviral tetrahydroimidazo [1,4]-benzodiazepines | JANSSEN PHARMACEUTICA N.V. (BE) | 1991-03-20 | — | — | EP | claimed |
| EP-0384522-A1 | Antiviral tetrahydroimidazo[1,4]benzodiazepin-2-thiones | JANSSEN PHARMACEUTICA N.V. (BE) | 1990-08-29 | — | — | EP | claimed |
| EP-0336466-A1 | Antiviral tetrahydroimidazo (1,4) benzodiazepin-2-ones | JANSSEN PHARMACEUTICA N.V. (BE) | 1989-10-11 | — | — | EP | claimed |
| JP-2270876-A | — | — | None | — | — | JP | disclosed |
| JP-1275582-A | — | — | None | — | — | JP | disclosed |
| EP-0538297-B9 | ANTIVIRAL TETRAHYDROIMIDAZO 1,4]BENZODIAZEPIN-2-(THIO)ONES | JANSSEN PHARMACEUTICA NV (BE) | 2002-10-16 | — | — | EP | disclosed |
| EP-0538297-B1 | ANTIVIRAL TETRAHYDROIMIDAZO 1,4]BENZODIAZEPIN-2-(THIO)ONES | JANSSEN PHARMACEUTICA NV (BE) | 2001-09-19 | — | — | EP | disclosed |
| JP-H02270876-A | ANTIVIRAL TETRAHYDROIMIDAZO(1,4)BENZODIAZEPIN-2-THIONE | JANSSEN PHARMACEUT NV | 1990-11-05 | — | — | JP | disclosed |
| EP-0384522-A1 | Antiviral tetrahydroimidazo[1,4]benzodiazepin-2-thiones | JANSSEN PHARMACEUTICA N.V. (BE) | 1990-08-29 | — | — | EP | disclosed |
| JP-H01275582-A | TETRAHYDROIMIDAZO(1,4)BENZODIAZEPIN-2-ONE COMPOUND | JANSSEN PHARMACEUT NV | 1989-11-06 | — | — | JP | disclosed |
| EP-0336466-A1 | Antiviral tetrahydroimidazo (1,4) benzodiazepin-2-ones | JANSSEN PHARMACEUTICA N.V. (BE) | 1989-10-11 | — | — | EP | disclosed |